[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-344384-en":59,"doc-seo-344384-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":72,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},344384,1099514068365,"Aurelia","https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Cell type composition in bulk prostate cancer tissue is a prognostic biomarker","Prostate cancer shows marked heterogeneity and variable clinical outcomes, demanding improved molecular subtyping for patient stratification. Whole-transcriptome bulk tissue RNA from four cohorts was analyzed to characterize primary tumor cell type composition using gene-expression deconvolution and multi-sample regional data to assess intrapatient heterogeneity. Three composition subtypes were defined—TCE, EPCE, and TASCE—then classified with a machine-learning model validated across three independent cohorts. Subtyping correlated with clinicopathological parameters and predicted biochemical recurrence, while interfocal heterogeneity exceeded intrafocal heterogeneity.","Neoplasia 72 (2026) 101272  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>Cell type composition in bulk prostate cancer tissue is a prognostic biomarker |  |  | |\n| --- | --- | --- | --- |\n| Xiaokang Zhang a,1 , Bjarne Johannessena , Susanne G. Kidda , Mari Bogaarda,b, Ane Strangera, Ulrika Axcronaa,b, Karol Axcronaa,c, Rolf I. Skotheima,d,* \u003Cbr>a Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway b Department of Pathology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway\u003Cbr>c Department of Urology, Akershus University Hospital, Lørenskog, Norway\u003Cbr>d Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Cell type composition Machine learning Molecular subtyping Multifocality Prognostic biomarker Prostate cancer |  | Prostate cancer, among the most prevalent cancer types globally, exhibits marked heterogeneity and varying disease progression and clinical outcomes. Improved molecular subtyping is needed for patient stratification. Since prostate cancer has relatively few somatic point mutations, whole-transcriptome data instead offers a rich and relevant source of molecular data. We analyzed bulk tissue transcriptomes from four cohorts to characterize primary prostate cancer’s cell type composition. A deconvolution of cell types was performed based on gene expression profiles. Patients with available multi-sample regional data from different tumor foci were analyzed for intrapatient heterogeneity. Three cell type composition subtypes were defined: T cells enriched (TCE), epithelial cells enriched (EPCE), and tumor-associated stromal cells enriched (TASCE). A machine learning model was developed to classify these subtypes and validated in three independent cohorts. The subtyping demonstrated a high correlation with established clinicopathological parameters (e.g., Gleason score, p-value \u003C 0.05), and the classifier showed a promising ability to predict biochemical recurrence. Moreover, our analysis revealed that interfocal heterogeneity in patients with multifocal cancer significantly surpassed intrafocal heterogeneity (p-value \u003C 0.05). In conclusion, this study provides a novel prostate cancer subgrouping based on cell type composition, with the TASCE subtype significantly associated with high biochemical recurrence risk. |  |\n\nIntroduction  \nProstate cancer is one of the most common cancer types affecting men worldwide, posing a significant clinical challenge and public health concern [1]. Despite advances in diagnostic methods and treatment strategies, stratification of localized prostate cancer to treatment strategies and accurately predicting patient outcomes remain grand challenges. An important research area in prostate cancer is thus enhancing the prognostication of patients with localized disease [2]. This would aid clinical decisions on who should undergo active surveillance and who should receive radical treatment – and for the latter, who would benefit from intensified treatment.  \nMolecular characterization of prostate cancer is complicated by the fact that most patients have multiple primary tumor foci upon diagnosis [3]. These tumors are both inter- and intrafocally heterogeneous,  \nmeaning that there is a coexistence of cells with different phenotypic and genomic characteristics across and within tumor foci [4–10]. Patients treated with radical prostatectomy experience biochemical relapse (BCR) of the disease at approximately 20% − 40% [11]. RNA-level data, including expression of protein-coding genes, long noncoding RNAs, and gene fusions, have been extensively studied for the development of molecular prognostic biomarkers for prostate cancer [5,12–16]","cbCaik5QNKsTCx62","https://ap.wps.com/l/cbCaik5QNKsTCx62","pdf",1619676,11,"English","en",105,"# Introduction\n## Tumor heterogeneity and molecular prognostication\n## Bulk transcriptome data and spatial transcriptomics\n## Tumor microenvironment and immune context","[{\"question\":\"What cell-type composition subtypes were defined in the study?\",\"answer\":\"The study defined three subtypes based on deconvolution of bulk tissue gene expression: T cells enriched (TCE), epithelial cells enriched (EPCE), and tumor-associated stromal cells enriched (TASCE).\"},{\"question\":\"How was heterogeneity assessed in multifocal prostate cancer patients?\",\"answer\":\"Patients with multi-sample regional data across different tumor foci were analyzed to evaluate intrapatient heterogeneity, including both inter-focal and intra-focal comparisons.\"},{\"question\":\"What clinical relevance did the machine-learning classifier show?\",\"answer\":\"The classifier’s subtyping correlated with established clinicopathological parameters and showed a promising ability to predict biochemical recurrence, with the TASCE subtype linked to higher recurrence risk.\"}]","Cell type composition in bulk prostate cancer tissue is a prognostic biomarker | PDF",1790053536,23,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef58ca4da17f849f525ffc3890fcee25.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a65b0b27cfe829168d962af52988024e.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a169f66565a51d09e50f5f43a1a7658.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e675911345148b2c77e4d3f30cd39e9.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"cell-type-composition-in-bulk-prostate-cancer-tissue-is-a-prognostic-biomarker","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/cell-type-composition-in-bulk-prostate-cancer-tissue-is-a-prognostic-biomarker/344384/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/cell-type-composition-in-bulk-prostate-cancer-tissue-is-a-prognostic-biomarker/344384.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":72},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What cell-type composition subtypes were defined in the study?","Question",{"text":146,"@type":147},"The study defined three subtypes based on deconvolution of bulk tissue gene expression: T cells enriched (TCE), epithelial cells enriched (EPCE), and tumor-associated stromal cells enriched (TASCE).","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How was heterogeneity assessed in multifocal prostate cancer patients?",{"text":151,"@type":147},"Patients with multi-sample regional data across different tumor foci were analyzed to evaluate intrapatient heterogeneity, including both inter-focal and intra-focal comparisons.",{"name":153,"@type":144,"acceptedAnswer":154},"What clinical relevance did the machine-learning classifier show?",{"text":155,"@type":147},"The classifier’s subtyping correlated with established clinicopathological parameters and showed a promising ability to predict biochemical recurrence, with the TASCE subtype linked to higher recurrence risk.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790331652]